-
1
-
-
0142058881
-
Lifestyle factors, obesity and the risk of chronic kidney disease
-
Stengel B., Tarver-Carr M. E., Power N. R. et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003;14:479.
-
(2003)
Epidemiology
, vol.14
, pp. 479
-
-
Stengel, B.1
Tarver-Carr, M.E.2
Power, N.R.3
-
2
-
-
0142244847
-
Risk factors for chronic kidney disease: A prospective study of 23, 534 men and women in Washington County, Maryland
-
Haroun M. K., Jaar B. G., Hoffman S. C. et al. Risk factors for chronic kidney disease: a prospective study of 23, 534 men and women in Washington County, Maryland. J Am Soc Nephrol 2003;14:2934.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 2934
-
-
Haroun, M.K.1
Jaar, B.G.2
Hoffman, S.C.3
-
3
-
-
4544313843
-
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
-
Iseki K., Ikemiya Y., Inoue T. et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004;44:642.
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 642
-
-
Iseki, K.1
Ikemiya, Y.2
Inoue, T.3
-
4
-
-
77955864512
-
Association of uric acid with change in kidney function in healthy normotensive individuals
-
Bellomo G., Venanzi S., Verdura C. et al. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis 2010;56:264.
-
(2010)
Am J Kidney Dis
, vol.56
, pp. 264
-
-
Bellomo, G.1
Venanzi, S.2
Verdura, C.3
-
5
-
-
0030979322
-
Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
-
Hunsicker L. G., Adler S., Caggiula A. et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997;51:1908.
-
(1997)
Kidney Int
, vol.51
, pp. 1908
-
-
Hunsicker, L.G.1
Adler, S.2
Caggiula, A.3
-
6
-
-
4544313843
-
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
-
Iseki K., Ikemiya Y, Inoue T. et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004;44(4):642-650.
-
(2004)
Am J Kidney Dis
, vol.44
, Issue.4
, pp. 642-650
-
-
Iseki, K.1
Ikemiya, Y.2
Inoue, T.3
-
7
-
-
12344324949
-
Uric acid and transplantation
-
Mazzali M. Uric acid and transplantation. Semin Nephrol 2005;25:50-55.
-
(2005)
Semin Nephrol
, vol.25
, pp. 50-55
-
-
Mazzali, M.1
-
8
-
-
57149091788
-
Elevated uric acid increases the risk for kidney disease
-
Obermayr R. P., Temml C., Gutjahr G. et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008;19:2407.
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 2407
-
-
Obermayr, R.P.1
Temml, C.2
Gutjahr, G.3
-
9
-
-
48049115805
-
Uric acid and incident kidney disease in the community
-
Weiner D. E., Tighiouart H., Elsayed E. E et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008;19:1204.
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1204
-
-
Weiner, D.E.1
Tighiouart, H.2
Elsayed, E.E.3
-
10
-
-
34447617704
-
Relationship of uric acid with progression of kidney disease
-
Chonchol M., Shlipak M. G., Katz R. et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 2007;50:239.
-
(2007)
Am J Kidney Dis
, vol.50
, pp. 239
-
-
Chonchol, M.1
Shlipak, M.G.2
Katz, R.3
-
11
-
-
80054055235
-
Uric acid as a mediator of diabetic nephropathy
-
Jalal D. J, Maahs D. M., Hovind P. et al. Uric acid as a mediator of diabetic nephropathy. Semin Nephrol 2011;31(5):459-465.
-
(2011)
Semin Nephrol
, vol.31
, Issue.5
, pp. 459-465
-
-
Jalal, D.J.1
Maahs, D.M.2
Hovind, P.3
-
12
-
-
84862649931
-
Effects of hyperuricemia on renal function of renal transplant recipients: A systematic review and meta-analysis of cohort studies
-
Yan Huang., Yu-Lin Li., He Huang Ling et al. Effects of Hyperuricemia on Renal Function of Renal Transplant Recipients: A Systematic Review and Meta-Analysis of Cohort Studies. PLoS One 2012;7(6):e39457.
-
(2012)
PLoS One
, vol.7
, Issue.6
-
-
Huang, Y.1
Li, Y.-L.2
Ling, H.H.3
-
13
-
-
27744608003
-
Essencial hypertension, progressive renal disease and uric acid: A pathogenic link?
-
Johnson R. S., Segal M. S., Sriniivas T. et al. Essencial hypertension, progressive renal disease and uric acid: a pathogenic link? J Am Soc Nephrol 2005;16:1990
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 1990
-
-
Johnson, R.S.1
Segal, M.S.2
Sriniivas, T.3
-
14
-
-
23244462442
-
Serum uric acid and CVD: Recent developments and where do they lead us?
-
Baker J. E., Krishnan E., Chen L., Schumacher R. Serum uric acid and CVD: recent developments and where do they lead us? Am J Med 2005;118:816.
-
(2005)
Am J Med
, vol.118
, pp. 816
-
-
Baker, J.E.1
Krishnan, E.2
Chen, L.3
Schumacher, R.4
-
15
-
-
84881392873
-
The association between serum uric acid and renal damage in a community-based population: The Takahata study
-
Nov. 27. Epub ahead of print
-
Ikeda A., Ichikawa K., Ueno Y. et al. The association between serum uric acid and renal damage in a community-based population: the Takahata study. Clin Exp Nephrol 2012 Nov. 27. [Epub ahead of print]
-
(2012)
Clin Exp Nephrol
-
-
Ikeda, A.1
Ichikawa, K.2
Ueno, Y.3
-
16
-
-
84871174888
-
Significance of serum uric acid levels in the risk of all-cause and cardiovascular mortality
-
Kuo C. E., See L. C., Yu K. H. et al. Significance of serum uric acid levels in the risk of all-cause and cardiovascular mortality. Reumatology (Oxford) 2013;52:127.
-
(2013)
Reumatology (Oxford)
, vol.52
, pp. 127
-
-
Kuo, C.E.1
See, L.C.2
Yu, K.H.3
-
17
-
-
3242785541
-
Uric acid levels as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study
-
Niskanen L. K., Laaksonen D. E., Nyyssonen K. et al. Uric acid levels as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:154.
-
(2004)
Arch Intern Med
, vol.164
, pp. 154
-
-
Niskanen, L.K.1
Laaksonen, D.E.2
Nyyssonen, K.3
-
18
-
-
0034630917
-
Serum uric acid and cardiovascular mortality the NHANES I Epidemiologic follow-up study, 1971-1992/National Health and Nutrition Examination Survey
-
Fang J., Alderman M. N. Serum uric acid and cardiovascular mortality the NHANES I Epidemiologic follow-up study, 1971-1992/National Health and Nutrition Examination Survey. JAMA 2000;283:2404.
-
(2000)
JAMA
, vol.283
, pp. 2404
-
-
Fang, J.1
Alderman, M.N.2
-
19
-
-
18244367869
-
Serum uric acid and CHD in 9, 458 incident cases and 155084 controls: Prospective study and meta-analysis
-
Wheeler J. G., Juzwishin K. D., Eiriksdottir G. et al. Serum uric acid and CHD in 9, 458 incident cases and 155084 controls: prospective study and meta-analysis. PloS Med 2005;2:e76
-
(2005)
PloS Med
, vol.2
-
-
Wheeler, J.G.1
Juzwishin, K.D.2
Eiriksdottir, G.3
-
20
-
-
84859924204
-
The correlation between uric acid and the incidence and prognosis of kidney diseases: A systematic review and meta-analysis of cohort studies
-
Li Y. L., Wang L., Li J., Huang Y., Yuan W. M. The correlation between uric acid and the incidence and prognosis of kidney diseases: a systematic review and meta-analysis of cohort studies. Zhonghua Nei Ke Za Zhi 2011;50(7):555-561.
-
(2011)
Zhonghua Nei Ke za Zhi
, vol.50
, Issue.7
, pp. 555-561
-
-
Li, Y.L.1
Wang, L.2
Li, J.3
Huang, Y.4
Yuan, W.M.5
-
21
-
-
5344274543
-
Effect of hyperuricemia upon endotelial function in patients at increased cardiovascular risk
-
Mercuro G., Vitale C. Effect of hyperuricemia upon endotelial function in patients at increased cardiovascular risk. Am J Cardiol 2004;94:932-935.
-
(2004)
Am J Cardiol
, vol.94
, pp. 932-935
-
-
Mercuro, G.1
Vitale, C.2
-
22
-
-
84855889639
-
Japanese Society of Gout and Nucleic Acid Metabolism. Japanese guideline for the management of hyperuricemia and gout: Second edition
-
Yamanaka H. Japanese Society of Gout and Nucleic Acid Metabolism. Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids 2011;30:1018.
-
(2011)
Nucleosides Nucleotides Nucleic Acids
, vol.30
, pp. 1018
-
-
Yamanaka, H.1
-
23
-
-
33746747096
-
MyD88-dependent IL-1 receptor signaling is essential forgouty inflammation stimulated monosodium urate crystals
-
Chen C. J., Shi Y, Hearn A. et al. MyD88-dependent IL-1 receptor signaling is essential forgouty inflammation stimulated monosodium urate crystals. J Clin Invest 2006;116(8):2262-2271.
-
(2006)
J Clin Invest
, vol.116
, Issue.8
, pp. 2262-2271
-
-
Chen, C.J.1
Shi, Y.2
Hearn, A.3
-
24
-
-
84862665366
-
Uric acid induces renal inflammation via activating tubular NF kB signaling pathway
-
Yang Zhou., Li Fang., Lei Jiang et al. Uric Acid Induces Renal Inflammation via Activating Tubular NF kB Signaling Pathway. PLoS One 2012;7(6):e39738.
-
(2012)
PLoS One
, vol.7
, Issue.6
-
-
Zhou, Y.1
Fang, L.2
Jiang, L.3
-
25
-
-
84874632085
-
Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease
-
Ryu E. S., Kim M. J., Shin H. S. et al. Uric Acid-induced Phenotypic Transition of Renal Tubular Cells as a Novel Mechanism of Chronic Kidney Disease. Am J Physiol Renal Physiol 2013;304(5):F471-480.
-
(2013)
Am J Physiol Renal Physiol
, vol.304
, Issue.5
-
-
Ryu, E.S.1
Kim, M.J.2
Shin, H.S.3
-
26
-
-
84881443040
-
RGC-32 mediates transforming growth FactorB2-induced epithelial- mesenchymal transition in human renal proximal tubular
-
HuangW-Y, Li Z-G. RGC-32 Mediates Transforming Growth FactorB2-induced Epithelial-Mesenchymal Transition in Human Renal Proximal Tubular. Cell Biol Chem 2009;284(14):942.
-
(2009)
Cell Biol Chem
, vol.284
, Issue.14
, pp. 942
-
-
Huang, W.-Y.1
Li, Z.-G.2
-
27
-
-
84881400902
-
Reducing Serum Uric Acid Attenuates TGF-P(1)-induced profibrogenic progression in type 2 diabetic nephropathy
-
Kim S. M., Choi Y. W., Seok H. Y. et al. Reducing Serum Uric Acid Attenuates TGF-P(1)-Induced Profibrogenic Progression in Type 2 Diabetic Nephropathy. Arthritis Rheum 2012;121(3-4): el09-el21.
-
(2012)
Arthritis Rheum
, vol.121
, Issue.3-4
-
-
Kim, S.M.1
Choi, Y.W.2
Seok, H.Y.3
-
28
-
-
67651056502
-
Meta-analysisof 28, 141 individuals identifies common variants within five new loci that influence uric acid concentrations
-
KolzM., Johnson T., TeumerA. et al. Meta-Analysisof 28, 141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations. PLoS Genet 2009;5(6): e 1000504.
-
(2009)
PLoS Genet
, vol.5
, Issue.6
-
-
Kolz, M.1
Johnson, T.2
Teumer, A.3
-
29
-
-
23844514428
-
Renal urate handling: Clinical relevance of recent advances
-
Anzai N., Enomoto A. Renal urate handling: clinical relevance of recent advances. Curr Rheumatol Rep 2005;7(3):227-234.
-
(2005)
Curr Rheumatol Rep
, vol.7
, Issue.3
, pp. 227-234
-
-
Anzai, N.1
Enomoto, A.2
-
30
-
-
0037047070
-
Allopurinol improves endothelial dysfunction in chronic heart failure
-
Colin A. J. Farguharson N. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002;106:221-226.
-
(2002)
Circulation
, vol.106
, pp. 221-226
-
-
Colin, A.J.1
Farguharson, N.2
-
31
-
-
0036083844
-
Hyperuricemia induces a primary renal arteriolopathy in rats by a BP-independent mechanism
-
Mazzali M., Kanellis J. Hyperuricemia induces a primary renal arteriolopathy in rats by a BP-independent mechanism. Am J Physiol - Renal Physiol 2002;282(561-566):F991-F997.
-
(2002)
Am J Physiol - Renal Physiol
, vol.282
, Issue.561-566
-
-
Mazzali, M.1
Kanellis, J.2
-
32
-
-
20244365646
-
Hyperuricemia induces endothelial dysfunction and vasoconstriction
-
Khosla U. N., Zharikov S., Finch J. I. et al. Hyperuricemia induces endothelial dysfunction and vasoconstriction. Kidn Intern 2005;67:1739-1742.
-
(2005)
Kidn Intern
, vol.67
, pp. 1739-1742
-
-
Khosla, U.N.1
Zharikov, S.2
Finch, J.I.3
-
33
-
-
77955071008
-
Review: Endothelial-myofibroblast transition, a new player in diabetic renal fibrosis
-
Li J., Bertram J. F. Review: Endothelial-myofibroblast transition, a new player in diabetic renal fibrosis. Nephrology (Carlton) 2010;15(5):507-512.
-
(2010)
Nephrology (Carlton)
, vol.15
, Issue.5
, pp. 507-512
-
-
Li, J.1
Bertram, J.F.2
-
35
-
-
0037024270
-
Effects of xanthine oxidase inhibition with allopurinol on endothelial dysfunction and periferial blood flow in hyperuricemic patients with heart failure: Results from 2 placebocontrolled studies
-
Doehner W, Schoene N. Effects of xanthine oxidase inhibition with allopurinol on endothelial dysfunction and periferial blood flow in hyperuricemic patients with heart failure: results from 2 placebocontrolled studies. Circulation 2002;105(22):2619-2624.
-
(2002)
Circulation
, vol.105
, Issue.22
, pp. 2619-2624
-
-
Doehner, W.1
Schoene, N.2
-
36
-
-
84881414085
-
Serum uric acid independently predicts cardiovascular events in advanced nephropathy
-
Kanbay M., Yilmaz M. I., Sonmez A. et al. Serum uric acid independently predicts cardiovascular events in advanced nephropathy. Am J Kidney Dis 2011;58(3):398-408.
-
(2011)
Am J Kidney Dis
, vol.58
, Issue.3
, pp. 398-408
-
-
Kanbay, M.1
Yilmaz, M.I.2
Sonmez, A.3
-
37
-
-
13844275419
-
Albuminuria as early test for vascular disease
-
RemuzziG., WeeningJ. J. Albuminuria as early test for vascular disease. Lancet 2005;365:556-557.
-
(2005)
Lancet
, vol.365
, pp. 556-557
-
-
Remuzzi, G.1
Weening, J.J.2
-
38
-
-
84891491159
-
Albuminuria is an independent predictor of all-cause and CV mortality in the Japanese population: The Takahata Study
-
Jan 24. Epub ahead of print
-
Konta T., Kudo K, Sato H. et al. Albuminuria is an independent predictor of all-cause and CV mortality in the Japanese population: the Takahata Study. Clin Exp Nephrol 2013 Jan 24. [Epub ahead of print]
-
(2013)
Clin Exp Nephrol
-
-
Konta, T.1
Kudo, K.2
Sato, H.3
-
39
-
-
77955729725
-
Effect of allopurinol in chronic kidney disease progression and cardiovascular risk
-
Goicoechea M., Garcfa De Vinuesa S. et al. Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk. Clin J Am Soc Nephrol 2010;5(8):1388-1393.
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, Issue.8
, pp. 1388-1393
-
-
Goicoechea, M.1
Garcfa De Vinuesa, S.2
-
40
-
-
84882818812
-
Effects of urate-lowering therapy in hyperuricemia on slowing the progression of renal function: A meta-analysis
-
Nov. 3. pii: S1051-2276 12 00172-0. doi: 10.1053/j.jrn. 2012.08.005. Epub ahead of print
-
Wang H., Wei YkongX., Xu D. Effects of Urate-Lowering Therapy in Hyperuricemia on Slowing the Progression of Renal Function: A Meta-Analysis. J Ren Nutr 2012 Nov. 3. pii: S1051-2276 (12) 00172-0. doi: 10.1053/j.jrn. 2012.08.005. [Epub ahead of print).
-
(2012)
J Ren Nutr
-
-
Wang, H.1
Wei, Y.2
Kong, X.3
Xu, D.4
-
41
-
-
84881438327
-
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level
-
Siu Y. P., Leung K. T., Tong M. K., Kwan T. H. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Ren Fail 2012;34(4):510-520.
-
(2012)
Ren Fail
, vol.34
, Issue.4
, pp. 510-520
-
-
Siu, Y.P.1
Leung, K.T.2
Tong, M.K.3
Kwan, T.H.4
-
42
-
-
33845447368
-
High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid
-
George J., Carr E., Davies J. et al. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006;114:2508-2516.
-
(2006)
Circulation
, vol.114
, pp. 2508-2516
-
-
George, J.1
Carr, E.2
Davies, J.3
-
43
-
-
77955719785
-
Effect of allopurinol on the BP of adolescents with newly diagnosed essencial hypertension
-
Feig D. L., Soletsky B. Effect of allopurinol on the BP of adolescents with newly diagnosed essencial hypertension. JAMA 2008;330:94-132.
-
(2008)
JAMA
, vol.330
, pp. 94-132
-
-
Feig, D.L.1
Soletsky, B.2
-
44
-
-
79959726530
-
Allopurinol, uric acid, and oxidative stress in cardiorenal disease
-
Riegersperger M., Covic A., Goldsmith D. Allopurinol, uric acid, and oxidative stress in cardiorenal disease. Int Urol Nephrol 2011;43(2):441-449.
-
(2011)
Int Urol Nephrol
, vol.43
, Issue.2
, pp. 441-449
-
-
Riegersperger, M.1
Covic, A.2
Goldsmith, D.3
-
45
-
-
76549098607
-
Uric acid-lowering treatment with benzbromarone in patients with heart failure: A double-blind placebo-controlled crossover preliminary study
-
Ogino K., Kato M., Furuse Y. et al. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail 2010;3:73-81.
-
(2010)
Circ Heart Fail
, vol.3
, pp. 73-81
-
-
Ogino, K.1
Kato, M.2
Furuse, Y.3
-
46
-
-
79959709376
-
Effect of a reduction in uric acid on renal outcomes during losartan treatment: A post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the angiotensin ii antagonist losartan trial
-
Afiao Y, Ottenbros SA., Laverman G. D. et al. Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial. Hypertension 2011;58(1):2-7.
-
(2011)
Hypertension
, vol.58
, Issue.1
, pp. 2-7
-
-
Afiao, Y.1
Ottenbros, S.A.2
Laverman, G.D.3
-
47
-
-
77951229146
-
Febuxostat: The evidence for its use in the treatment of hyperuricemia and gout
-
Gaffo A. L., Saag KG. Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout. Core Evid 2010;4:25-36.
-
(2010)
Core Evid
, vol.4
, pp. 25-36
-
-
Gaffo, A.L.1
Saag, K.G.2
|